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Proteomic, Functional, and Domain-Based Analysis
of In Vivo 14-3-3 Binding Proteins Involved
in Cytoskeletal Regulation and Cellular Organization
(GEF) for the Rho GTPase. 14-3-3 binding to AKAP-Lbc,
induced by PKA, suppresses Rho activation in vivo.
Conclusion: 14-3-3 proteins can potentially engage
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Summary proteins interact through phosphorylated motifs that di-
verge from this consensus [8], and in some cases 14-
Background: 14-3-3 proteins are abundant and con- 3-3 proteins can also recognize unmodified proteins
served polypeptides that mediate the cellular effects of [9–11].
basophilic protein kinases through their ability to bind 14-3-3 proteins are abundant and are encoded by
specific peptide motifs phosphorylated on serine or seven mammalian genes (/, , , , /, /	, and 
)
threonine. that can be traced through vertebrates, plants, and yeast
Results: We have used mass spectrometry to analyze [10]. They typically form stable homo- and heterodimers
proteins that associate with 14-3-3 isoforms in HEK293 as a result of reciprocal contacts between their N-ter-
cells. This identified 170 unique 14-3-3-associated pro- minal  helices. These dimers therefore present a rather
teins, which show only modest overlap with previous rigid structure with two distinct, but closely apposed,
14-3-3 binding partners isolated by affinity chromatog- phosphopeptide binding sites and potentially serve as
raphy. To explore this large set of proteins, we devel- adaptors to juxtapose two separate phosphoproteins
oped a domain-based hierarchical clustering technique [4]. However, a more common role may be as allosteric
that distinguishes structurally and functionally related regulators that stabilize their binding partners in a partic-
subsets of 14-3-3 target proteins. This analysis revealed ular conformation. Thus, a 14-3-3 dimer appears to
a large group of 14-3-3 binding partners that regulate clamp serotonin N-acetyltransferase in an enzymatically
cytoskeletal architecture. Inhibition of 14-3-3 phospho- active configuration [5]. 14-3-3 proteins can also regu-
protein recognition in vivo indicates the general impor- late the formation of multi-protein complexes by binding
tance of such interactions in cellular morphology and to one component of such an assembly and restricting
membrane dynamics. Using tandem proteomic and bio- its access to other partners. The binding of 14-3-3 to
chemical approaches, we identify a phospho-depen- phosphorylated BAD to block its pro-apoptotic associa-
dent 14-3-3 binding site on the A kinase anchoring pro- tion with Bcl-XL is an example [12]. Alternatively, 14-3-3
tein (AKAP)-Lbc, a guanine nucleotide exchange factor proteins can restrict the subcellular location of their li-
gands, typified by retention of the 14-3-3-associated
FoxO transcription factor FKHR in the cytoplasm [13].*Correspondence: pawson@mshri.on.ca
6These two authors made equal contributions. Consistent with this view, analysis of individual 14-3-3
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binding partners in cells, as well as large-scale identifi- known to associate with 14-3-3s (see notes in Table 1).
Furthermore, control experiments indicated that anti-cation of potential 14-3-3 ligands by in vitro affinity chro-
matography, has revealed a number of diverse polypep- Flag precipitates from parental HEK293 cells had little
background. As a positive control, Flag-14-3-3 immu-tides that can potentially associate with 14-3-3 proteins
[14, 15]. noprecipitates were eluted with a GST fusion containing
a 20 amino acid peptide (R18) that binds to the 14-3-3Here, we have used a direct proteomic analysis of
14-3-3 binding proteins in HEK293 (human embryonic phosphopeptide recognition pocket and displaces as-
sociated phosphoproteins [17, 18]. The proteins elutedkidney) cells. Our results identify in vivo 14-3-3 binding
partners that are associated with a remarkable range by Flag or R18 peptides were largely identical, except
that both bait and endogenous 14-3-3 proteins wereof cellular activities but show only partial overlap with
previous proteomic analysis of in vitro 14-3-3 targets. absent from the R18 eluate, as anticipated (Figure S2).
This observation, taken with the finding that treatmentTo understand this large volume of information, we have
developed a domain-based clustering approach that of cells with Calyculin-A (an inhibitor of the PP1 and
PP2A phosphatases) increased the overall binding ofidentifies and visualizes multiple subsets of 14-3-3 bind-
ing proteins. A significant group of 14-3-3 binding pro- cellular proteins to 14-3-3 (data not shown), indicates
that the majority of proteins are associated with 14-3-3teins distinguished through this approach is involved in
control of the cytoskeleton. We have employed a cell- through pSer/Thr recognition.
based approach to analyze the general role of 14-3-3
proteins in controlling cell morphology. We also de-
Domain-Based Cluster Analysis Identifies Relatedscribe a specific cytoskeletal regulator, AKAP-Lbc, that
Sets of 14-3-3-Associated Proteinswas identified in tandem proteomic and biochemical
Peptides identified by MS/MS analysis were assignedscreens for 14-3-3 binding partners that are also scaf-
to specific protein GI (GenInfo Identifier, National Centerfolds and substrates for basophilic kinases. Activation
for Biotechnology Information [NCBI]) numbers; theseof the Rho GTPase by AKAP-Lbc is regulated by 14-3-3
were filtered, and redundancies were removed primarilyin a cAMP-dependent manner.
based on their LocusID numbers (see Supplemental
Experimental Procedures for details) (Tables 1 and S3).
In total, we identified 170 unique 14-3-3-associatedResults and Discussion
proteins implicated in a broad range of cellular activities;
only a few of these proteins are potentially nonspecificIsolation of 14-3-3 Protein Complexes
from HEK293 Cells (proteins also identified in control TrCP immuopre-
cipitates are marked in Table 1). All identified proteinsHEK293 cells were transiently transfected with plasmids
encoding Flag-tagged human /, /	, , or / isoforms were characterized according to GO (Gene Ontology
Consortium, http://www.geneontology.org/) categoriesof 14-3-3. 14-3-3 complexes were isolated with immobi-
lized anti-Flag antibodies, and the associated proteins that define their biological and molecular functions [19],
as indicated in Figure 1 and Table 1. The largest groupwere released upon incubation with a Flag peptide.
These protein mixtures were separated by gel electro- of 14-3-3-interacting proteins is involved in cellular com-
munication and signal transduction (45%). Significantphoresis, stained with colloidal Coomassie blue dye
(Figure S1 in the Supplemental data available with this numbers of 14-3-3 targets are also implicated in cellular
organization (10%), energy and metabolism (3%), andarticle online), excised, and digested with trypsin. The
resulting peptides were analyzed by LC-tandem mass nucleic acid synthesis and processing (15%), among
others. A schematic summary of the 14-3-3-associatedspectrometry (MS/MS) and assigned to specific proteins
with the Mascot search engine. As shown in Table S1, proteins that fall into each of these functional categories,
with further annotation of their molecular function, ismany proteins were identified in association with each
isoform (/, 71; , 127; /, 19; and /	, 26), with Flag- presented in Figure 1. This figure also identifies a signifi-
cant proportion (approximately 60%) of proteins that14-3-3 yielding the largest number of interactions. To
avoid problems of overexpression associated with tran- contain a 14-3-3 mode 1 binding consensus [20] (for
details, also see Table S2).sient transfection, we isolated a HEK293 cell line that
stably expresses Flag-14-3-3 at a level similar to that of This analysis indicates that 14-3-3 interacting proteins
potentially amount to approximately 0.6% of the humanendogenous isoforms (data not shown) for subsequent
analysis. proteome, suggesting pleiotropic functions for 14-3-3
proteins in cells. We have taken advantage of the modu-The most prominent Flag-14-3-3 binding partners
identified by LC-MS/MS in this stably expressing cell lar nature of cell regulatory proteins to obtain an over-
arching view of 14-3-3-mediated interactions and to ex-line were the seven endogenous 14-3-3 isoforms (Figure
S2), consistent with the ability of 14-3-3 proteins to form plore whether this large number of proteins can be
further grouped into functional or structural subsets. Tohomo- and heterodimers [16]. The immunopreciptation
approach can therefore capture proteins that interact this end, we employed a hierarchical clustering ap-
proach, commonly used to analyze and visualize mi-not only with ectopic Flag-14-3-3, through either direct
or indirect association, but also with endogenous 14-3-3 croarray data, by grouping genes according to similari-
ties in their expression patterns [21]. For our purposes,isoforms. Several observations suggest that the 14-3-3-
associated proteins detected in this screen are biologi- we identified interaction and catalytic domains present
in each 14-3-3 binding protein, as predicted by SMARTcally relevant. In addition to a large set of novel 14-3-3
partners, we isolated a significant fraction of proteins (Simple Modular Architecture Research Tool) and Pfam
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Table 1. 14-3-3 Interacting Proteins
(continued)
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Table 1. Continued
14-3-3-associated proteins identified by LC-MS/MS are listed according to their unique LocusLink gene symbols. Each protein is described
by its various names (NCBI protein accession descriptions) and domain composition (obtained from SMART [http://dylan.embl-heidelberg.de/] and
Pfam [http://pfam.wustl.edu/]), with domains listed in order from N to C terminus. Proteins are grouped according to their GO biological and
molecular functions (annotated in NCBI LocusLink and the Human Protein Reference Database [www.hprd.org] for the proteins or close
relatives). The color code for GO biological functions is given in Figure 1. References in notes are provided in the Supplemental Data.
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Figure 1. Functional Grouping of 14-3-3 In-
teracting Proteins
Each 14-3-3-interacting protein (Table 1) is
illustrated as a node (individual circle). Pro-
teins are grouped according to their GO bio-
logical functions, such as “cellular communi-
cation and signal transduction” (color-coded
background in each segment). Each separate
protein is color coded for its GO molecular
properties, such as “protein kinase.” Proteins
with potential mode 1 14-3-3 binding motifs
are distinguished by solid black circles
around the relevant nodes.
(Protein Family Database) (see Supplemental Experi- GTPase binding domains) [22–27]. The green cluster is
focused on proteins implicated in membrane associa-mental Procedures and Table S3 for details). We then
used a statistical algorithm based on the average-link- tion and actin regulation or as scaffolds for signaling
pathways. A feature of these proteins is the presence ofage method to establish a similarity metric that relates
proteins based on the correlation coefficiency of their PH, RhoGEF (DH), RhoGAP, SH3, PDZ, or PTB domains,
among others. Proteins in the blue cluster have varieddomains, and vice versa. This unbiased procedure yields
a two-dimensional hierarchical clustering matrix, which functions, with a common theme being trafficking and
the dynamic organization of larger subcellular struc-groups proteins that have similar binding or enzymatic
domains and may therefore participate in related biolog- tures. For example, Liprin- and Erc1b regulate vesicle
docking at presynaptic active zones, Rabaptin-5, Rab-ical processes (Figures 2 and S3–S8).
In this map (Figure 2), individual proteins are shown FIP, and RCP regulate membrane recycling, and kinesin
and dynein govern motor activity, whereas 53BP2,on the horizontal axis and are colored according to their
functional GO annotation, with a dendrogram (generated hsRAD50, and C-NAP1 control DNA and chromosome
stability [28, 29]. A frequent element of these proteinsby TreeView programming [21]) that reflects the phylo-
genic order of proteins and domains in the cluster map. is the presence of contractile domains (i.e., Myosin tail
1 and MAD domains).Proteins with a closely related set of modular domains,
such as protein kinases or PH domain-containing pro- This analysis shows that a significant fraction of 14-
3-3-associated proteins can be grouped into subsetsteins, will cluster together in the horizontal dimension.
The vertical axis shows the presence or absence of with related domains and, by inference, with related
functions. We have exploited this approach to compareindividual modular domains in a given protein (for example,
PDZ, SH3, or RhoGEF domains). Consequently, the map 14-3-3-interacting proteins obtained with different tech-
niques. Two recent proteomic studies have employedreflects the relatedness of 14-3-3 binding proteins ac-
cording to their domain structure (a detailed list of pro- the in vitro binding of human HeLa cell proteins to
immobilized yeast Bmh1/Bmh2 14-3-3 proteins [14] orteins with full domain annotation is given in Table S3).
Strikingly, this approach yields a number of prominent 14-3-3- [15] to identify associated proteins. We have
compared the results from these studies with proteinsclusters, of which three are shown in more detail (see
the red, green, and blue boxes in Figures 2 and 3). The identified here that coprecipitate from HEK293 cells with
Flag-tagged 14-3-3 isoforms. To this end, we combinedred cluster contains primarily protein serine/threonine
kinases, which also possess a number of non-catalytic the data obtained from “in vitro” binding into a single,
non-redundant group, and similarly amalgamated themodules that direct their interactions with regulators or
substrates (i.e., the PB1 heterodimerization domain and interacting proteins we identified from stable and tran-
Functional Proteomics of 14-3-3 Binding Proteins
1441
Figure 2. Comprehensive Analysis of 14-3-3 Binding Proteins by Domain-Based Hierarchical Clustering
SMART and Pfam definitions were used for analyzing sequences from each 14-3-3 binding protein for their domain composition. Proteins
were then ranked by hierarchical clustering based on their domain content. In the resulting map, proteins (identified by GI numbers and color
coded for their GO biological function as in Figure 1) are arrayed on the x axis, and domains from SMART and Pfam are on the y axis. A
yellow square indicates the presence of a given domain within a specific protein sequence. The ordering of proteins and domains along the
two axes depends on the hierarchical clustering process; the relationships of proteins and domains are also defined by phylogenic trees, as
shown. Three prominent clusters are indicated by red, green, and blue boxes. Magnified versions of these three clusters are shown in Figure
3, with the proteins identified by specific names (see Supplemental Experimental Procedures for details).
sient transfections into an “in vivo” set. When these F) (see Figure S5–S8 for expanded versions of all clus-
ters). The coclustering of 14-3-3 binding proteins identi-in vivo or in vitro datasets were individually subjected to
domain-based clustering, they yielded distinct patterns fied through different approaches argues that the physi-
ological processes represented by each group are broad(Figure S4). Consistent with this, there is only a partial
overlap (approximately 26%) between the 14-3-3 bind- targets for control by 14-3-3 proteins. Of particular inter-
est, box G (Figures S5–S8) represents an expanded ver-ing proteins identified by in vivo and in vitro techniques,
potentially because of differences in the purification pro- sion of the green cluster in Figure 2 and contains a
diverse series of proteins involved in cytoskeletal regula-cedures or the use of different cells (Figure 4; for details,
see Supplemental Experimental Procedures). tion, control of Rho, Rab, and Rap family GTPases,
membrane signaling, trafficking, focal adhesions, andTo obtain a more comprehensive view, the “in vitro”
and “in vivo” groups were pooled and then clustered by cell polarity. This grouping of proteins that control cell
architecture and adhesion demonstrates the utility ofdomains (Figure 4). Interestingly, this integrated dataset
shows that 14-3-3 binding proteins identified by copre- domain-based clustering in identifying functionally inter-
connected polypeptides within a large dataset.cipitation (this study; colored yellow) or in vitro affinity
purification [14, 15] (colored blue) frequently cocluster
in specific groups (i.e., Figure 4, boxes B, D, and F–I). 14-3-3 Binding Proteins Have Diverse Functions
The clustering analysis of in vivo 14-3-3 binding proteinsFor example, specific coclusters contain protein kinases
(box H), cytoskeletal regulators, polarity proteins, and suggests that 14-3-3 proteins can impinge simultane-
ously on multiple facets of cellular behavior, consistentsignaling scaffolds (box G), as well as proteins involved
in trafficking, dynamics, and contractile functions (box with the functional annotations in Figure 1 and Table 1.
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Figure 3. Magnified Versions of the Three Prominent Clusters Shown in Figure 2
In signal transduction, we identified 18 protein Ser/Thr as well as heterotrimeric G protein signaling, by phos-
pho-dependent 14-3-3 interactions.kinases and 24 molecular adaptors, as well as several
serine/threonine phosphatase components and a phos- 14-3-3s bind metabolic proteins [8], notably phos-
phorylated 6-phosphofructo-2-kinase (6PF-2-K), whichphatidylinositol (PI) 5-phosphatase [30], suggesting
that 14-3-3 proteins regulate the balance of cellular pro- contains an N-terminal kinase domain and a C-terminal
phosphatase domain (PGAM). In addition to 6PF-2-K,tein and lipid phosphorylation through association with
both kinases and phosphatases. Of interest, we obtained we found a novel 14-3-3-associated protein, MGC5352
(listed under “unclassified” in Table 1), which sharesmultiple members of specific protein kinase families
(MARK, PAK, and Ste11-related MAPKKK) as well as homology with the 6PF-2-K’s PGAM domain but lacks
the kinase domain. It will be of interest to test whetherkinases with novel or poorly studied 14-3-3 binding proper-
ties (i.e., WNK1, PKN, DYRK1A, MRK, and CaMKK). this protein participates in glycolytic regulation. In this
vein, a significant number of 14-3-3-associated proteinsAmong these are disease-implicated gene products, in-
cluding the Arg-directed kinase DYRK1A implicated in are poorly characterized (unclassified) but have known
interaction domains indicative of signaling functionsDown’s Syndrome [31, 32] as well as WNK1, which is
mutated in pseudohyperaldosternism type II, resulting (i.e., FHA, SH3, PDZ, SAM, TPR, ANK, WD40, BTB, and
RA) and frequently possess consensus mode 1 14-3-3in hypertension [33].
Novel 14-3-3-associated proteins are also involved in recognition sites (Figure 1 and details in Table S2).
both heterotrimeric and monomeric G protein-depen-
dent signaling (Table 1). Among these are proteins that 14-3-3-Associated Proteins in Regulation
of the Cytoskeleton and Cell Polaritydirectly regulate Gi, and 14 guanine nucleotide ex-
change factors (GEF) and GTPase activating proteins As noted, numerous proteins identified in this screen are
involved in regulation of the actin cytoskeleton, polarity,(GAP) for Rho, Arf, and Rap GTPases. In addition, we
have found small-GTPase effector proteins, including focal adhesions, and endocytosis (summarized in Figure
5A). Cell polarity and asymmetric cell division are con-Rab GTPase targets, and Rho family-dependent protein
kinases such as PRK2/PKN and PAK1/4. These data trolled by a conserved network of interacting proteins,
identified genetically in C. elegans as the products ofargue for significant control of small-GTPase pathways,
Functional Proteomics of 14-3-3 Binding Proteins
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Figure 4. Comparison of In Vivo and In Vitro 14-3-3 Binding Proteins by Hierarchical Domain Clustering
Domain-based hierarchical clustering was applied to a combined dataset of 14-3-3-associated proteins, including proteins identified by
coprecipitation from stable or transiently transfected cells (“in vivo” set) and proteins identified by affinity chromatography (“in vitro” set) [14,
15]. Proteins are identified by LocusID numbers or gene symbols, and only those proteins (approximately 80%) with accession numbers
annotated in LocusLink are included. Proteins in the in vivo dataset are color coded yellow, and those in the in vitro set are blue, with proteins
in common between the two groups in green. The Venn diagram indicates the overlap between the in vivo and in vitro datasets. Prominent
clusters are indicated by boxes labeled A-I, and magnified versions of these clusters are shown in Figures S5–S8. Note the coclustering of
14-3-3 binding proteins obtained by distinct approaches within several of these groups.
par genes, of which par-5 encodes a 14-3-3 protein [34, include the Nck binding protein NCKAP/NAP125 as well
as PIR121 [42]. A NAP125-PIR121-Abi1 complex has35]. By binding to phosphorylated polarity proteins, 14-
3-3 isoforms can potentially control their assembly into been implicated in the activation of WAVE by the Nck
SH2/SH3 adaptor and GTP bound Rac [43]. In addition,larger complexes and regulate their polarized subcellu-
lar distribution. Consistent with this theme, we identified we identified IRSp53, an adaptor implicated in filopodial
formation through interactions with Mena and Cdc42several polarity determinants, including the PDZ domain
scaffolding protein Par-3, its interacting kinase PKC, [44], and also in lamellipodial extensions through asso-
ciation with WAVE and Rac [45]. We also identified aand the Par-1A kinase [36–38], as well as the cell fate
protein Numb-R, in association with 14-3-3 [39]. In ad- member of the srGAP/WRP family of Rho GTPases,
FNBP2; we have previously shown that the related WRP/dition, we found cell junction proteins including Afadin,
ZO-2A/TJP2, Plakophilin 2, and p120 catenin, as well as srGAP3 is a Rac GAP that binds through its SH3 domain
to WAVE-1 and thereby attenuates Rac-induced actinproteins with a polarized subcellular localization; such
proteins include Apical Protein of Xenopus-Like (APXL), polymerization [46].
Multiple isoforms of all members of the PAK/Pix/GITwhich regulates amiloride-sensitive sodium channel ac-
tivity [40, 41]. complex were found to associate with 14-3-3 (Table 1
and Figure 5A). These proteins have functions in proteinWe also identified novel 14-3-3-associated proteins
directly involved in regulating actin polymerization and trafficking, the formation of focal adhesions, and cell
motility [27, 47]. Taken with the identification of multiplebranching through their ability to interact with WAVE
isoforms, which in turn bind the Arp2/3 complex. These Rho GTPase regulators and microtubule-associated
Current Biology
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Figure 5. 14-3-3 Phospho-Dependent Interactions Control Dynamic Cell Morphology
(A) 14-3-3 interacting proteins have multiple functions in cytoskeletal regulation and cell fate determination. Solid lines connect 14-3-3 to
proteins identified in this study, and dashed lines represent reported interactions. Only a subset of cytoskeletal regulators is shown here (for
details, see text and notes in Table 1).
(B) The R18 peptide fused to EGFP fluorescent proteins binds 14-3-3 in transfected cells. Flag-14-3-3 HEK293 cells were transfected with
expression vectors encoding wild-type (WT) or mutant (MUT) R18 peptides fused to ECFP or EYFP respectively, or EGFP alone. The R18MUT
sequence has a substitution that converts WLDL to WLRL. Anti-Flag immunoprecipitates were blotted with antibodies to EGFP for detection
of R18 fusion proteins (top panel).
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proteins, these data indicate that 14-3-3 proteins may can recruit proteins such as Nck, N-WASP, and Arp2/3
to sites of actin assembly through viral gene productsplay a direct role in multiple facets of cellular architec-
ture (Figure 5A). [49]. We propose that inhibition of 14-3-3 interactions
with associated actin regulatory proteins, such as those
identified by proteomic analysis, may underlie the ef-In Vivo Inhibition of 14-3-3 Phosphopeptide
Binding Modifies Membrane Dynamics fects of the R18 peptide.
14-3-3 activity does not appear essential for main-and Cell Shape
To explore the role of 14-3-3 proteins in cellular morphol- taining tight junctions (Figure 5D). However, to assess
whether blocking 14-3-3 binding impairs the establish-ogy, we examined the effects of blocking 14-3-3 phos-
phopeptide binding activity in vivo. This was accom- ment of these cellular structures, we depolarized the
R18-expressing MDCK cells and assessed their abilityplished with a plasmid that encodes the wild-type (WT)
R18 peptide fused to enhanced cyan fluorescent protein to reform tight junctions with neighboring cells. Cells
with higher levels of R18WT expression failed to form(ECFP); wild-type R18 peptide antagonizes binding of
phosphorylated cellular proteins to 14-3-3 (Figure 5B). tight junctions with adjacent cells, as indicated by an
absence of ZO-1 staining at cell borders, whereasAs a control, we used an EYFP-fused variant R18 pep-
tide (R18MUT), which no longer binds 14-3-3 because R18MUT was without effect (Figure S9). These experi-
ments suggest that phospho-dependent 14-3-3 interac-of a substitution (WLRL for WLDL) in the core motif
(Figure 5B). MDCK (Madin-Darby Canine Kidney) epithe- tions are broadly important for cytoskeletal and mem-
brane dynamics and for controlling contact inhibitionlial cells in a confluent, polarized monolayer were mi-
croinjected with vectors expressing either R18WT-ECFP and the organization of cell junctions.
(Figure 5C, in blue) or R18MUT-EYFP control (Figure 5C,
in green) and examined for expression of the fluores- PKA Suppresses AKAP-Lbc RhoGEF Activity
through Phospho-Dependent Bindingcently labeled R18 proteins and for their morphology
and migration. The most striking difference between the of 14-3-3 to Ser1565
To address more specifically the role 14-3-3 plays intwo groups of cells was that the R18WT cells exhibited
enhanced local movement in the form of membrane controlling actin dynamics, we sought 14-3-3 targets
that can link basophilic protein kinases to the regulationruffling and blebbing at the cell periphery, 3 hr after
injection. These cells exhibited dynamic and reversible of actin polymerization. PKA (cAMP-dependent protein
kinase) has a substrate specificity consistent with phos-protrusive membrane structures, which were highly fluo-
rescent and suggestive of interaction of the inhibitory phorylation of 14-3-3 binding sites. Furthermore, PKA
activity is directed to specific substrates through tar-R18 peptide with 14-3-3 proteins at these sites (high-
lighted in Figure 5C; time-lapse video clip Movie 1). geting interactions of its regulatory (R) subunits with A
kinase anchoring proteins [50–52]. Therefore, we con-After more prolonged R18WT expression, polarized
MDCK cells developed an abnormal morphology, dis- sidered the possibility that PKA phosphorylation might
promote the recruitment of 14-3-3 to AKAP signalingplayed unusual long, branched extensions in compari-
son to their R18MUT counterparts (Figure 5D), and complexes. We used an RII overlay approach to identify
AKAPs that coprecipitated with Flag-14-3-3 fromfrequently crawled under their neighbors (image not
shown). We quantitated this aberrant cell morphology HEK293 cells. This technique identified a 14-3-3-associ-
ated, RII binding protein of 250 kDa (Figure 6A, upperby measuring the length of a cell’s longest horizontal
axis (XEGFP), referenced to the diameter of the same cell panel). Binding of the AKAP to 14-3-3 was enhanced
upon forskolin/IBMX treatment (compare lanes 3 andobtained from cell-cell junction protein ZO-1 (zona oc-
cludens 1) staining (YZO-1). The ratios of XEGFP/YZO-1 for 4), suggesting that PKA phosphorylation creates novel
14-3-3 binding sites on this protein. Several AKAPs havecells expressing R18WT and R18MUT peptides (Figure
5E) show that disrupting 14-3-3 phospho-dependent a molecular weight in this range, and we therefore at-
tempted to identify the anchoring protein by Westernbinding had a significant effect (p  0.05) on cell shape.
Similar results were obtained with NIH 3T3 fibroblasts blotting with a panel of AKAP-specific antibodies.
A 250 kDa protein that coprecipitated with 14-3-3, in(Figure 5F). Of interest, this cytoskeletal remodeling is
reminiscent of the effects of vaccinia virus [48], which a fashion that was enriched upon PKA activation, was
(C) Fluorescent video microscopy of MDCK cells expressing ECFP-R18. ECFP-R18WT and EYFP-R18MUT plasmids were microinjected into
a patch of polarized MDCK cells. After 3 hr, the fluorescent proteins were detected; ECFP-R18WT is shown in blue (right), and EYFP-R18MUT
is shown in green (left). Video microscopic images of a fixed viewing field were captured over a period of 25 min and show a dynamic
distribution of fluorescently labeled R18 peptide in cells (A full-episode video clip is available as Movie 1). Sites of membrane blebbing induced
by R18WT protein are highlighted.
(D) R18-expressing MDCK cells extend aberrant protrusions. Fully polarized MDCK cells were transfected with EGFP-R18WT or EGFP-R18MUT
fusion proteins. Twenty-four hours after transfection, cells were fixed and stained for ZO-1 as a marker of cellular tight junctions (red). In
contrast to R18MUT-transfected cells, R18WT cells (EGFP, green) showed long protrusions (see arrows), which extended far beyond the ZO-1
cellular margins.
(E) Quantitation of abnormal cell morphologies induced by R18. Thirty randomly selected cells expressing R18WT and 30 cells expressing
R18MUT were measured for their longest axis and diameter under EGFP-R18 and ZO-1 filters, respectively. The ratios of these two parameters
(XEGFP/YZO-1) were plotted as mean values, with error bars representing standard deviations.
(F) NIH 3T3 fibroblasts were transfected with either R18WT-EGFP or R18MUT-EGFP plasmids and imaged for EGFP after 24 hr. R18WT cells
show aberrant protrusions.
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Figure 6. Phosphorylation-Dependent Inter-
action of AKAP-Lbc with 14-3-3
(A) HEK293 cells were either mock trans-
fected or transfected with a vector express-
ing Flag-tagged 14-3-3. Cells were stimulated
with either vehicle control or a forskolin/IBMX
mix (20 M/75 M) for 10 min at 37C. Flag-
14-3-3 was immunopreciptated, and proteins
were separated and transferred to nitrocellu-
lose membranes. Membranes were incu-
bated with 32P-labeled PKA RII subunit to
identify RII binding proteins. An RII binding
protein 250 kDa was identified (top panel).
Binding of this protein to 14-3-3 increased
after PKA activation by forskolin/IBMX treat-
ment (lanes 3 and 4). Western blotting with
specific antisera identified this protein as
AKAP-Lbc (middle panel). Blotting with 14-3-3
antisera confirmed the presence of 14-3-3 in
Flag immunoprecipitates but not in immuno-
precipitates from mock-transfected cells
(bottom panel).
(B) Schematic diagram of AKAP-Lbc showing
the regions of the protein that were expressed
as GST fusion proteins in bacteria. The PKA
binding site (PKA) and C1, DH-PH (RhoGEF),
and coiled-coil (CC) domains are indicated.
Two potential PKA phosphorylation sites as
determined by Scansite analysis are shown.
The first site, serine 1565, also falls within a
predicted mode 1 14-3-3 binding site.
(C) GST-AKAP-Lbc fusion proteins were purified from bacteria and phosphorylated in vitro with purified PKA catalytic subunit and -32P-ATP.
Proteins separated by SDS-PAGE were stained with Coomassie blue (top panel) and exposed to film for determination of 32P incorporation
(bottom panel).
(D) Equivalent amounts of GST-AKAP-Lbc fusion proteins were either phosphorylated in vitro with PKA or left unphosphorylated. Both sets
of fusion proteins were then incubated with freshly prepared HEK293 cell lysate for 2 hr at 4C. After being washed and separated by SDS-
PAGE, membranes were probed with pan-14-3-3 antisera. The AKAP-Lbc fragment containing amino acids 1388–1922 binds 14-3-3 upon
phosphorylation by PKA (top panel), whereas no binding to any of the fragments is observed when they are not phosphorylated (bottom
panel). Input corresponds to 1% of the amount of HEK293 lysate incubated with each fusion protein.
specifically detected with AKAP-Lbc antisera (Figure 6A, was located within a putative mode 1 14-3-3 binding
site (Figure 6B). Site-directed mutagenesis studies dem-middle panel, lanes 3 and 4). In contrast, negative results
were obtained when similar filters were probed with onstrated that substitution of serine1565 by alanine
significantly reduced PKA phosphorylation of the AKAP-antisera against Gravin/AKAP250 or AKAP350/450 (data
not shown). Independent confirmation of this result was Lbc 1388–1922 fragment (Figure 7A, lane 3) when com-
pared to the wild-type fragment (Figure 7A, lane 2). Thisprovided by LC-MS/MS when multiple peptides from
AKAP-Lbc were identified in the proteomic analysis of suggests that Ser1565 is the principal PKA phosphoryla-
tion site in this region of AKAP-Lbc. In vitro bindingin vivo 14-3-3 binding partners (Table 1; Figure S10).
AKAP-Lbc clusters with the group of cytoskeletal regu- studies demonstrated that a GST fusion of AKAP-Lbc
residues 1388–1922 was unable to bind 14-3-3 after pre-lators (Figure 3, green box; Figure 4, box G) because of
the presence of a DH-PH RhoGEF cassette, and indeed incubation with PKA when Ser1565 was mutated to Ala
(Figure 7B).AKAP-Lbc is a Rho-specific GEF competent for actin
regulation [53]. Wild-type (WT) or mutant AKAP-Lbc proteins were
then expressed and immunoprecipitated from HEK293We have recently shown that AKAP-Lbc is phosphory-
lated by its own pool of anchored PKA [54]. We detected or COS-7 cells, and immune complexes were blotted
for 14-3-3. The S1565A mutation strongly reduced bothtwo prominent PKA phosphorylation sites located be-
tween residues 1388 and 1922 and residues 2337 and basal and forskolin/IBMX-induced 14-3-3 interaction
with AKAP-Lbc (Figure 7C). Collectively, these data2817 of AKAP-Lbc by screening GST fusion proteins
that encompass overlapping regions of the anchoring identify Ser1565 of AKAP-Lbc as a specific phospho-
dependent 14-3-3 binding site, modified by PKA in vivo.protein (Figures 6B and 6C, both panels). In vitro, 14-
3-3 bound strongly and selectively to the PKA phosphor- To investigate whether phosphorylation of Ser1565
may regulate the RhoGEF activity of AKAP-Lbc, we usedylated fragment of AKAP-Lbc containing amino acids
1388–1922 (Figure 6D, lane 5). Control experiments con- two complementary assays to analyze the effect of the
S1565A mutation on the ability of full-length AKAP-Lbcfirmed that 14-3-3 did not bind to the non-phosphory-
lated AKAP-Lbc 1388–1922 fragment (Figure 6D). Scan- to stimulate GTP bound Rho in vivo. In one approach,
we employed a FRET (fluorescent resonance energysite analysis of this region detected one consensus PKA
phosphorylation site at serine1565, which interestingly transfer)-based technique to specifically measure the
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Figure 7. PKA Phosphorylation of AKAP-Lbc
Ser1565 Mediates 14-3-3 Binding.
(A) Serine 1565 in GST-AKAP-Lbc 1388–1922
was mutated to alanine and expressed in
bacteria. GST fusion proteins were phosphor-
ylated in vitro by PKA as described. Proteins
separated by SDS-PAGE were stained with
Coomassie blue (bottom panel) and exposed
to film for determination of 32P incorporation
(top panel). Mutation of S1565 to alanine
largely abolished PKA phosphorylation of this
fusion protein, indicating this residue is the
major site of PKA phosphorylation in this re-
gion of AKAP-Lbc (top panel).
(B) GST-AKAP-Lbc 1388–1922 and GST-
AKAP-Lbc 1388–1922 S1565A were phos-
phorylated in vitro by PKA or left unphosphor-
ylated. Fusion proteins were then incubated
with HEK293 cell lysate for 2 hr at 4C. After
washing and SDS-PAGE, membranes were
Western blotted for 14-3-3 (top panel). Muta-
tion of serine 1565 to alanine abolishes PKA
phosphorylation-induced binding of GST-
AKAP-Lbc 1388–1922 to 14-3-3. GST and
GST-AKAP-Lbc 2337–2817 were used as
controls. Input represents 1% of the HEK293
lysate added to the fusion proteins. Ponceau
staining demonstrates equal loading of fusion
proteins (bottom panel).
(C) Flag-tagged full-length AKAP-Lbc WT or
AKAP-Lbc S1565A cDNAs expressed in COS-7
cells. Cells were treated with vehicle or with
forskolin/IBMX (20 M/75 M) for 10 min at
37C. Flag-agarose was used for immunopur-
ification of AKAP-Lbc proteins from lysates. After SDS-PAGE and transfer, membranes were probed with pan-14-3-3 antisera. Forskolin/IBMX
treatment increases the amount of 14-3-3 associated with wild-type AKAP-Lbc. Mutation of serine1565 to alanine reduces basal 14-3-3 binding
and abolishes forskolin/IBMX-induced AKAP-Lbc-14-3-3 interactions (top panel). Equivalent amounts of 14-3-3 in the lysates (middle panel)
and precipitated AKAP-Lbc proteins (bottom panel) were confirmed by Western blotting.
ratio of active GTP bound RhoA to inactive GDP bound 2), whereas the S1565A mutant was unaffected by ele-
vated cAMP and attendant PKA activation (Figure 8B).RhoA by using NIH 3T3 cells transfected with WT AKAP-
Lbc or the S1565A mutant. We measured the state of In both sets of experiments, the expression of WT and
S1565A mutant proteins was equivalent (data not shown).Rho activation by using a RhoA-Raichu probe [55] that
contains the Rho GTPase joined to the Rho-GTP binding These findings are consistent with a model in which cAMP
activates a pool of PKA anchored to AKAP-Lbc to cata-domain of PKN, with yellow fluorescence protein (YFP)
and cyan fluorescence protein (CFP) fused to the N- or lyze the phosphorylation of Ser 1565. The concomitant
recruitment of 14-3-3 suppresses AKAP-Lbc RhoGEFC termini, respectively. When the RhoA component of
the RhoA-Raichu chimera is bound to GTP, it associates activity. This scheme provides a molecular explanation
for evidence that cAMP-responsive events attenuatewith the linked GTPase binding domain and thereby
juxtaposes YFP and CFP such that they undergo FRET. Rho activation [51]. Furthermore, this pathway provides
a direct means to link PKA activity to RhoA and theBoth the WT and S1565A mutant forms of AKAP-Lbc
stimulated RhoA GTP loading in control cells treated formation of actin stress fibers through the 14-3-3-medi-
ated control of AKAP-Lbc.only with the phosphodiesterase inhibitor IBMX (Figure
8A). However, upon treatment with both forskolin and
IBMX to elevate cAMP and activate PKA, WT AKAP-Lbc Conclusion
We have used tandem proteomic and biochemical tech-no longer induced RhoA activation (Figure 8A, column
5). In contrast, the S1565A mutant of AKAP-Lbc retained niques to identify polypeptides that are associated with
14-3-3 proteins in vivo. These approaches provide anfull RhoGEF activity in the presence of forskolin/IBMX
(Figure 8A, column 7; consistent results were obtained important, physiological counterpart to the analysis of
14-3-3 binding proteins by in vitro affinity chromatogra-in three separate experiments).
In complementary experiments, we used a GST-Rho- phy and have revealed a distinct spectrum of 14-3-3
binding proteins. Our data have uncovered a broad rangetekin fusion, which selectively binds Rho-GTP, to moni-
tor the extent of Rho activation in COS-7 cells express- of 14-3-3-associated proteins with numerous potential
functions. In order to understand and exploit this largeing WT or mutant AKAP-Lbc by using a pull-down assay.
Once again, we found that forskolin/IBMX stimulation amount of information, we have devised a domain-
based clustering approach to analyze this relatively sig-of cells transfected with WT AKAP-Lbc suppressed the
level of Rho-GTP by approximately 35% (Figure 8B, lane nificant fraction of the proteome. This technique defines
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Figure 8. Phosphorylation of Ser1565 Sup-
presses AKAP-Lbc RhoGEF Activity against
RhoA
(A) The fraction of GTP bound RhoA-Raichu
was measured in NIH 3T3 cells. NIH 3T3 cells
were transiently cotransfected with the Rai-
chu plasmids containing activated (Q63L) or
wild-type (WT) RhoA, together with AKAP-
Lbc expression vectors (WT, S1565A) as indi-
cated. The cells were then serum starved for
24 hr, followed by addition of IBMX (control)
or both IBMX and forskolin (FSK/IBMX). Ten
minutes later, cells were lysed, and fluores-
cence emission spectra from the lysates were
subsequently collected. Each bar represents
the averaged normalized ratio of fluores-
cence at 528  (FRET) over 480  (non-FRET)
from two separate transfections with their
standard deviation.
(B) RhoA activity of WT AKAP-Lbc and AKAP-
Lbc S1565A was measured with rhotekin RBD
pulldowns. COS-7 cells transfected with vec-
tors expressing HA-RhoA and either AKAP-
Lbc or AKAP-Lbc S1565A were serum starved
for 6 hr and treated with vehicle or forskolin/
IBMX (20 M/75 M) for 10 min at 37C.
Cleared lysates were incubated with immobi-
lized GST-RBD for 1 hr at 4C. After extensive washing, bound proteins were separated by SDS-PAGE, and blots were probed with anti-HA
antisera. Forskolin/IBMX treatment results in an inhibition of WT AKAP-Lbc GEF activity and decreased Rho-GTP (top panel). This effect is
abolished upon serine 1565 mutation to alanine in the PKA phosphorylation/14-3-3 binding site (top panel). Rho-GTP levels were normalized
to total Rho present in cell lysates (middle panel) and quantified by densitometry (bottom panel).
specific subsets of structurally related 14-3-3 interacting ysis of differential protein complexes could be exploited
as a means to explore the extent of 14-3-3 interactions,proteins, which are thereby implicated in common as-
pects of cellular regulation. We propose that this compu- and thus protein phosphorylation, under different physi-
ological or pathological conditions.tational approach will be of general utility in the analysis
of large protein datasets.
Supplemental DataA notable feature of 14-3-3 binding proteins revealed
Supplemental Experimental Procedures, a movie, three tables, andby this procedure is their involvement in regulation of
ten supplemental figures are available with this article online atthe cytoskeletion, GTPase function, membrane signal-
http://www.current-biology.com/cgi/content/full/14/16/1436/DC1/.
ing, and cell fate determination. The significance of
these proteomic data is supported by the effects of
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